Canada Network Point-of-care Glucose Testing Market Size & Outlook
Related Markets
Canada network point-of-care glucose testing market highlights
- The Canada network point-of-care glucose testing market generated a revenue of USD 86.0 million in 2023 and is expected to reach USD 105.1 million by 2030.
- The Canada market is expected to grow at a CAGR of 2.8% from 2024 to 2030.
- In terms of segment, accu-chek inform ii was the largest revenue generating product in 2023.
- CareSens Expert Plus is the most lucrative product segment registering the fastest growth during the forecast period.
Network point-of-care glucose testing market data book summary
| Market revenue in 2023 | USD 86.0 million |
| Market revenue in 2030 | USD 105.1 million |
| Growth rate | 2.8% (CAGR from 2024 to 2030) |
| Largest segment | Accu-chek inform ii |
| Fastest growing segment | CareSens Expert Plus |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
Other key industry trends
- In terms of revenue, Canada accounted for 6.5% of the global network point-of-care glucose testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. network point-of-care glucose testing market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 536.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Network Point-of-Care Glucose Testing Market Scope
Network Point-of-Care Glucose Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Nova Biomedical | View profile | 501-1000 | Waltham, Massachusetts, United States, North America | http://www.novabio.us |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Canada network point-of-care glucose testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 49.3% in 2023. Horizon Databook has segmented the Canada network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2018 to 2030.
The demand for rapid and preventive diagnosis has been increasing in Canada over the years. The need to develop efficient products aiding in early diagnosis has encouraged local market players to develop glucose testing products that can assist in making better treatment alternatives.
Rapid transition by common people in the country toward self-glucose testing to avoid frequent visits to laboratories has positively influenced the market growth.
Moreover, focus of government organizations on offering appropriate training and spreading awareness pertaining to glucose POC testing products is expected to benefit glucometer users, thereby increasing their demand in the market.
Reasons to subscribe to Canada network point-of-care glucose testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada network point-of-care glucose testing market databook
-
Our clientele includes a mix of network point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Canada network point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada network point-of-care glucose testing market size, by product, 2018-2030 (US$M)
Canada Network Point-of-Care Glucose Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
